WST
West Pharmaceutical Services
Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: WST
- Earnings
EPS in 2026 (TTM): $7.52
Last Report Period Date: Mar 31, 2026
As of June 2026, WST's current EPS stands at $7.52, according to the latest financial reports. West Pharmaceutical Services's EPS for 2025 amounted to $6.83, marking an increase from $6.75 in 2024. WST reported an EPS of $1.93 for the quarterly report ending on Mar 31, 2026.
WST earnings history
For 2025, West Pharmaceutical Services's EPS was $6.83, an increase of 1.2% from $6.75 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $1.93, indicating a 55.6% increase from the same quarter last year. WST's 12-month EPS stands at $7.52 as of March 2026. West Pharmaceutical Services's annual EPS in 2024 stood at $6.75, a 15.4% decrease year-over-year.
WST earnings chart
WST EPS growth history
West Pharmaceutical Services has registered an increase in EPS of 55.6% during the last 12 months (YoY, quarterly). In the last three years, WST recorded an average annual EPS growth rate of -4.6%. West Pharmaceutical Services had an average annual EPS growth rate of 7.9% during the last 5 years. Across the last decade, WST had an average annual EPS growth of 17.8%.
WST Earnings Waterfall
WST Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MDT Medtronic plc | 21.5 | 3.3% | 9.8% | 6.9% |
| JNJ Johnson & Johnson | 27.39 | 90.6% | 17.7% | 14.8% |
| SYK Stryker Corp | 35.47 | 8% | 10.9% | 14.8% |
| BDX Becton Dickinson & Co | 36.44 | -0.9% | -0.6% | 16.2% |
| WST West Pharmaceutical Services Inc | 44.73 | 1.2% | -4.6% | 7.9% |
| ICUI Icu Medical Inc | 72.47 | 100.6% | N/A | -62.7% |
| BAX Baxter International Inc | N/A | -47.2% | N/A | N/A |
| TFX Teleflex Inc | N/A | -1,462.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.